InsidersTradesSigma
Track the PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025 share price and the full management transaction log of the company, a listed equity based in Italy. Shares are listed on the IT market, under the authority of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025 has published 0 public disclosures. Market capitalisation: €794.7m. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA S.P.A. is a company in the health and pharmaceutical sector, specializing in the research and development of nutraceutical products. The company recently had its board of directors approve the interim management report as of September 30, 2025.